Structure-based validation can drastically underestimate error rate in proteome-wide cross-linking mass spectrometry studies.
Where this comes from
- Record sourced from PubMed, PMID 32994567.
- Also identified by DOI 10.1038/s41592-020-0959-9 and PMC identifier 7534832.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Thorough quality assessment of novel interactions identified by proteome-wide cross-linking mass spectrometry (XL-MS) studies is critical. Almost all current XL-MS studies have validated cross-links against known three-dimensional structures of representative protein complexes. Here, we provide theoretical and experimental evidence demonstrating that this approach can drastically underestimate error rates for proteome-wide XL-MS datasets, and propose a comprehensive set of four data-quality metrics to address this issue.
Medical subject headings
- Mass Spectrometry
- Proteome
- Proteomics